Year |
Citation |
Score |
2024 |
Wu R, Zhang Z, Xu Q, Liu F, Zhan Y, Wang Q, Du L, Tang X. Integration of network pharmacology and experimental verifications reveals the Bian-Se-Tong mixture can alleviate constipation in STC rats by reducing apoptosis of Cajal cells via activating PI3K-Akt signaling pathway. Heliyon. 10: e28022. PMID 38586320 DOI: 10.1016/j.heliyon.2024.e28022 |
0.326 |
|
2018 |
Ran L, Murphy D, Sher J, Cao Z, Wang S, Walczak E, Guan Y, Xie Y, Shukla S, Zhan Y, Antonescu CR, Chen Y, Chi P. Abstract A15: Modeling sporadic gastrointestinal stromal tumor with BRAFV600E mutation Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A15 |
0.311 |
|
2017 |
Shukla S, Cyrta J, Murphy DA, Walczak EG, Ran L, Agrawal P, Xie Y, Chen Y, Wang S, Zhan Y, Li D, Wong EWP, Sboner A, Beltran H, Mosquera JM, et al. Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer Cell. PMID 29153843 DOI: 10.1016/J.Ccell.2017.10.008 |
0.302 |
|
2017 |
Ran L, Murphy D, Sher J, Cao Z, Wang S, Walczak E, Guan Y, Xie Y, Shukla S, Zhan Y, Antonescu CR, Chen Y, Chi P. ETV1-positive cells give rise to BRAFV600E mutant gastrointestinal stromal tumors. Cancer Research. PMID 28539323 DOI: 10.1158/0008-5472.Can-16-3510 |
0.325 |
|
2016 |
Zhan Y, Seregin SS, Chen J, Chen GY. Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183588 DOI: 10.4049/Jimmunol.1501822 |
0.357 |
|
2014 |
Liu S, Sun X, Wang M, Hou Y, Zhan Y, Jiang Y, Liu Z, Cao X, Chen P, Liu Z, Chen X, Tao Y, Xu C, Mao J, Cheng C, et al. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells. Gastroenterology. 147: 847-859.e11. PMID 24931456 DOI: 10.1053/J.Gastro.2014.06.006 |
0.334 |
|
2012 |
Zhan Y, Abi Saab WF, Modi N, Stewart AM, Liu J, Chadee DN. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells. Experimental Cell Research. 318: 1641-8. PMID 22652451 DOI: 10.1016/J.Yexcr.2012.05.002 |
0.615 |
|
2011 |
Zhan Y, Modi N, Stewart AM, Hieronimus RI, Liu J, Gutmann DH, Chadee DN. Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer. Oncogene. 30: 781-9. PMID 20890305 DOI: 10.1038/Onc.2010.453 |
0.777 |
|
2010 |
Zhan Y, Chadee DN. Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin. Small Gtpases. 1: 183-186. PMID 21686274 DOI: 10.4161/Sgtp.1.3.14935 |
0.752 |
|
2009 |
Cole ET, Zhan Y, Abi Saab WF, Korchnak AC, Ashburner BP, Chadee DN. Mixed lineage kinase 3 negatively regulates IKK activity and enhances etoposide-induced cell death. Biochimica Et Biophysica Acta. 1793: 1811-8. PMID 19782705 DOI: 10.1016/J.Bbamcr.2009.09.014 |
0.626 |
|
2009 |
Korchnak AC, Zhan Y, Aguilar MT, Chadee DN. Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. Cellular Signalling. 21: 1620-5. PMID 19586614 DOI: 10.1016/J.Cellsig.2009.06.008 |
0.722 |
|
Show low-probability matches. |